1,5-Dibromopentane | CAS:111-24-0

We serve 1,5-Dibromopentane CAS:111-24-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1,5-Dibromopentane

Chemical Name:1,5-Dibromopentane
CAS.NO:111-24-0
Synonyms:1,5-Dibromopentane
PENTAMETHYLENE DIBROMIDE
1,5 DIBROMPENTANE
Pentane, 1,5-dibromo-
1 5-DIBROMOPENTANE
Molecular Formula:C5H10Br2
Molecular Weight:229.94100
 
Physical and Chemical Properties:
Density:1.688
Melting point:-34ºC
Boiling point:110ºC
Flash point:>230°F
Index of Refraction:1.512
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay(GC):≥98.5%
Moisture:≤1.0%
pH:6-8
Color:≤50 APHA
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 1,5-Dibromopentane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1 5-DIBROMOPENTANE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,5-Dibromopentane Use and application,1,5 DIBROMPENTANE technical grade,usp/ep/jp grade.


Related News: Russia, which had temporarily stopped issuing work visas to Chinese citizens, is also halting visa-free entry for Chinese tour groups, the government said. Moscow has also stopped issuing electronic tourist visas to individual Chinese travelers.Docosahexaenoic Acid manufacturer The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported.tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate supplier It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.N-Boc-piperazine vendor According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.